Government Owned Invention Available for License: Chimeric Antigen Receptors Targeting the Gamma Delta (Ξ³Ξ΄) T-Cell Receptor
Notice
Health and Human Services Department, National Institutes of Health
Notice
July 16, 2026
2026-14344
π Summary
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a set of Chimeric Antigen Receptors (CARs) that target the [gamma][delta] T-Cell Receptor.
